Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

2.950 -0.270 (-8.39%)
Streaming Delayed Price Updated: 1:46 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
General Motors Posts Upbeat Q3 Results, Joins Halliburton, Danaher, Crown Holdings And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
3 Stocks Under $10 We Approach with Caution
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
2 Unprofitable Stocks to Target This Week and 1 Facing Challenges
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
3 Cash-Burning Stocks We’re Skeptical Of
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership... 
Via MarketMinute
Topics Artificial Intelligence ETFs Intellectual Property
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
3 Reasons to Sell CLOV and 1 Stock to Buy Instead
Over the past six months, Clover Health’s shares (currently trading at $2.63) have posted a disappointing 18.1% loss, well below the S&P 500’s 32.7% gain. This may have investors wondering how to... 
Via StockStory
Topics Stocks Supply Chain
SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why. 
Via Benzinga
Clover Health, GoodRx, Cardinal Health, McKesson, and Humana Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
3 Inflated Stocks We Think Twice About
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
3 Cash-Heavy Stocks We Approach with Caution
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Why Clover Health (CLOV) Stock Is Trading Up Today
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.9% in the morning session after its wholly-owned subsidiary, Counterpart Health, announced a major upgrade to its AI-powered... 
Via StockStory
Topics Economy
2 Volatile Stocks for Long-Term Investors and 1 We Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
Health Insurance Providers Stocks Q2 In Review: Clover Health (NASDAQ:CLOV) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Prediction: Chamath Palihapitiya's $250 Million SPAC Could Create the Next Palantir for America's Energy Grid
Chamath Palihapitiya is launching a $250 million SPAC, called American Exceptionalism Acquisition Corp. 
Via The Motley Fool
Topics Artificial Intelligence Economy
FTAI Infrastructure, Acadia Healthcare, agilon health, Clover Health, and Evolent Health Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy World Trade
1 Growth Stock Set to Flourishand 2 We Avoid
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the poor performance track record. 
Via Benzinga
3 Unprofitable Stocks with Open Questions
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, Defense
Venture capitalist Chamath Palihapitiya, once dubbed the "SPAC King," is returning to Wall Street with a new blank-check deal. 
Via Benzinga
Topics Artificial Intelligence
Is the Market Bullish or Bearish on Clover Health Investments?
 
Via Benzinga
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
CLOV Q2 Deep Dive: Membership Growth and Cost Pressures Define Quarter
Health insurance company Clover Health (NASDAQ:CLOV) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 34.1% year on year to $477.6 million. Its non-GAAP loss of $0.02 per share was... 
Via StockStory
3 Small-Cap Stocks That Concern Us
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Friday's after hours session: top gainers and losers
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Why Clover Health (CLOV) Stock Is Nosediving
Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 20.3% in the afternoon session after the company reported mixed second-quarter results where rising medical costs and a... 
Via StockStory
Clover Health (CLOV) Q2 Sales Up 34%
Via The Motley Fool
Clover Health (NASDAQ:CLOV) Beats Q2 Sales Targets But Stock Drops
Health insurance company Clover Health (NASDAQ:CLOV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 34.1% year on year to $477.6 million. Its GAAP loss of $0.02 per... 
Via StockStory
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.